We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $10.1B
1-Year Est. Return 42.88%
This Fund
S&P 500
This Quarter Est. Return
+15.03%
1 Year Est. Return
+42.88%
3 Year Est. Return
+92.52%
5 Year Est. Return
+113.84%
10 Year Est. Return
+608.05%
AUM
$10.8B
AUM Growth
+$1.01B
Cap. Flow
-$186M
Cap. Flow %
-1.72%
Top 10 Hldgs %
9.41%
Holding
962
New
55
Increased
332
Reduced
336
Closed
102

Top Buys

Rank Stock Value
1
AAP icon
Advance Auto Parts
AAP
+$36.7M
2
VVV icon
Valvoline
VVV
+$18M
3
NGVT icon
Ingevity
NGVT
+$16.9M
4
IBP icon
Installed Building Products
IBP
+$16M
5
GSAT icon
Globalstar
GSAT
+$15M

Top Sells

Rank Stock Value
1
AVID
Avid Technology Inc
AVID
+$31.5M
2
FTAI icon
FTAI Aviation
FTAI
+$17.7M
3
WIRE
Encore Wire Corp
WIRE
+$17.4M
4
FOXF icon
Fox Factory Holding Corp
FOXF
+$17.1M
5
RBA icon
RB Global
RBA
+$14.5M

Sector Composition

Rank Sector Weight
1 Industrials 26.58%
2 Technology 19.03%
3 Financials 13.73%
4 Consumer Discretionary 13%
5 Materials 8.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MKTX icon
801
MarketAxess Holdings
MKTX
$4.47B
$417K ﹤0.01%
1,423
– –
KYMR icon
802
Kymera Therapeutics
KYMR
$8.66B
$407K ﹤0.01%
+16,004
New +$286K
PRMW
803
DELISTED
Primo Water Corporation
PRMW
$403K ﹤0.01%
26,791
– –
FATE icon
804
Fate Therapeutics
FATE
$275M
$401K ﹤0.01%
107,318
+76,979
+254% +$182K
ECC
805
Eagle Point Credit Company
ECC
$497M
$400K ﹤0.01%
42,054
– –
EMKR
806
DELISTED
Emcore Corp
EMKR
$386K ﹤0.01%
78,840
– –
FDMT icon
807
4D Molecular Therapeutics
FDMT
$502M
$380K ﹤0.01%
+18,769
New +$247K
TVTX icon
808
Travere Therapeutics
TVTX
$5.17B
$374K ﹤0.01%
41,641
+23,302
+127% +$170K
RSKD icon
809
Riskified
RSKD
$719M
$373K ﹤0.01%
79,637
+34,822
+78% +$143K
RMAX icon
810
RE/MAX Holdings
RMAX
$198M
$373K ﹤0.01%
+27,947
New +$307K
AMR icon
811
Alpha Metallurgical Resources
AMR
$1.77B
$365K ﹤0.01%
1,078
-1
-0.1% -$263
BRDG
812
DELISTED
Bridge Investment Group
BRDG
$361K ﹤0.01%
36,937
+3,807
+11% +$30.9K
CLPT icon
813
ClearPoint Neuro
CLPT
$424M
$360K ﹤0.01%
+53,065
New +$300K
PRME icon
814
Prime Medicine
PRME
$547M
$353K ﹤0.01%
+39,837
New +$307K
RLAY icon
815
Relay Therapeutics
RLAY
$4B
$353K ﹤0.01%
+32,025
New +$270K
RYAM icon
816
Rayonier Advanced Materials
RYAM
$562M
$348K ﹤0.01%
85,855
– –
FIP icon
817
FTAI Infrastructure
FIP
$447M
$347K ﹤0.01%
89,132
+29,882
+50% +$105K
ZIP icon
818
ZipRecruiter
ZIP
$339M
$333K ﹤0.01%
+23,980
New +$296K
XFOR icon
819
X4 Pharmaceuticals
XFOR
$377M
$326K ﹤0.01%
12,945
+8,978
+226% +$218K
SMG icon
820
ScottsMiracle-Gro
SMG
$4.09B
$319K ﹤0.01%
5,000
-13,220
-73% -$714K
CUTR
821
DELISTED
Cutera, Inc.
CUTR
$315K ﹤0.01%
89,500
-140,750
-61% -$429K
MRIN
822
DELISTED
Marin Software
MRIN
$310K ﹤0.01%
141,099
-16,750
-11% -$36.5K
ERII icon
823
Energy Recovery
ERII
$420M
$301K ﹤0.01%
16,000
-32,000
-67% -$594K
ENV
824
DELISTED
ENVESTNET, INC.
ENV
$297K ﹤0.01%
6,000
– –
AVDL
825
DELISTED
Avadel Pharmaceuticals
AVDL
$296K ﹤0.01%
+20,981
New +$246K
31 32
33
34 35

Similar funds

GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return
IIM
INTECH Investment Management West Palm Beach, Florida $10.2B AUM 28.14% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VPIM
Vanguard Personalized Indexing Management Oakland, California $10.2B AUM 34.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
OIA
OneDigital Investment Advisors Overland Park, Kansas $10.2B AUM 16.58% 1-Year Est. Return
LWCFA
Loring Wolcott & Coolidge Fiduciary Advisors Boston, Massachusetts $9.98B AUM 4.97% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Royce & Associates's Q4 2023 Portfolio in Review

As of Q4 2023, Royce & Associates held 962 positions worth $10.8B, up 10% from $9.82B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.

Royce & Associates's Q4 2023 filing shows 55 new, 332 increased, 336 reduced and 102 closed positions. Its largest new stake was Advance Auto Parts: 670,596 shares worth $40.9M. The largest sale was Avid Technology Inc, an estimated $31.5M.

By sector, the portfolio is most concentrated in Industrials at 27% of assets, down from 28% a quarter earlier, followed by Technology and Financials.

  • Royce & Associates's largest Q4 2023 buy was Advance Auto Parts: 670,596 shares worth $40.9M.
  • Royce & Associates added most to Valvoline in Q4 2023, an estimated $18M increase.
  • Royce & Associates's biggest Q4 2023 reduction was FTAI Aviation, cutting an estimated $17.7M.
  • Royce & Associates fully exited Avid Technology Inc in Q4 2023, selling an estimated $31.5M.
  • Royce & Associates's ten largest holdings make up 9.4% of its $10.8B portfolio in Q4 2023.
  • Royce & Associates opened 55 new positions and closed 102 in Q4 2023.
  • Royce & Associates's portfolio value rose 10% quarter-over-quarter to $10.8B.

Based on Royce & Associates's 13F filing for Q4 2023, filed 12 Feb 2024.